{
    "name": "deoxycholic acid",
    "comment": "Rx",
    "other_names": [
        "Kybella"
    ],
    "classes": [
        "Aesthetic Surgery Products"
    ],
    "source": "https://reference.medscape.com/drug/kybella-deoxycholic-acid-999993",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies in pregnant women to inform the drug-associated risk",
            "Animal data: Embryofetal development studies performed in rats and rabbits using SC doses administered during the period of organogenesis; for the basis of comparing animal to human doses, the maximum recommended human dose (MRHD) is 1.7 mg/kg (100 mg/60 kg); no evidence of fetal harm was observed in rats at up to the highest dose tested (50 mg/kg), which is 5-fold higher than the MRHD of deoxycholic acid based on a mg/mÂ² comparison"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Unknown if distributed in human breast milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Presence of infection at the injection sites"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness (paresis), were reported during clinical trials; do not inject into or in close proximity to the marginal mandibular branch of the facial nerve",
                "Difficulty swallowing (dysphagia) occurred in clinical trials in the setting of administration site reactions (eg, pain, swelling, and induration of the submental area); current or prior history of dysphagia may exacerbate the condition; avoid use in these patients",
                "Injection site hematoma/bruising reported in 72% of patients treated; caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur",
                "Risk of injecting in proximity to vulnerable anatomic structures; to avoid potential tissue damage, should not be injected into or in close proximity (1-1.5 cm) to salivary glands, lymph nodes, and muscles",
                "Injection site alopecia have been reported; consider withhold subsequent treatment until resolution",
                "Injections that are too superficial (into the dermic) may result in skin ulceration, necrosis, and infection; some cases of injection site infection have included cellulitis and abscess requiring intravenous antibiotic treatment and incision and drainage; do not administer into affected area until complete resolution"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Edema",
            "percent": "87"
        },
        {
            "name": "swelling at injection sites",
            "percent": "72"
        },
        {
            "name": "Hematoma",
            "percent": "70"
        },
        {
            "name": "bruising",
            "percent": "66"
        },
        {
            "name": "Pain",
            "percent": "27"
        },
        {
            "name": "Numbness",
            "percent": "23"
        },
        {
            "name": "Erythema",
            "percent": "14"
        },
        {
            "name": "Induration",
            "percent": "13"
        },
        {
            "name": "Paresthesia",
            "percent": "12"
        },
        {
            "name": "Nodule",
            "percent": "8"
        },
        {
            "name": "Pruritus",
            "percent": "5"
        },
        {
            "name": "Headache",
            "percent": "4"
        },
        {
            "name": "Skin tightness",
            "percent": "4"
        },
        {
            "name": "Site warmth",
            "percent": "3"
        },
        {
            "name": "Nerve injury",
            "percent": "3"
        },
        {
            "name": "Oropharyngeal pain",
            "percent": "2"
        },
        {
            "name": "Hypertension",
            "percent": "2"
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Dysphagia",
            "percent": null
        },
        {
            "name": "Ulceration",
            "percent": null
        },
        {
            "name": "necrosis",
            "percent": null
        },
        {
            "name": "infection",
            "percent": null
        },
        {
            "name": "and alopecia at injection site",
            "percent": null
        },
        {
            "name": "Immune system disorders",
            "percent": null
        },
        {
            "name": "Hypersensitivity reactions including rash",
            "percent": null
        },
        {
            "name": "urticaria",
            "percent": null
        },
        {
            "name": "and itching",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Oral hypoaesthesia and oral paraesthesia",
            "percent": null
        },
        {
            "name": "Administration site conditions",
            "percent": null
        },
        {
            "name": "Scarring",
            "percent": null
        }
    ]
}